BROSSARD, QUEBEC — (Marketwired) — 02/16/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening software and algorithm development, data analysis, and image processing, announces today that a pilot program for diabetic retinopathy screening will be carried out for one of the two main Public Health Institutions in Mexico.Diabetic retinopathy is the most common diabetic eye disease and a leading ca
BROSSARD, QUEBEC — (Marketwired) — 02/12/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the opening of its Polish Subsidiary, Diagnos Poland spolka z ograniczona odpowiedzialnoscia (Sp. z o.o.)."Poland–s central European location and substantial diabetic population, along with the strong suppor
BROSSARD, QUEBEC — (Marketwired) — 01/21/15 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today that a screening program for Vision-Threatening Diseases (VTD) offered to clientele in AZUR retirement residences.The screening program, in which DIAGNOS wants to gradually introduce its VTD screening services i
BROSSARD, QUEBEC — (Marketwired) — 12/11/14 — DIAGNOS Inc. ("DIAGNOS" or the "Company") (TSX VENTURE: ADK), a leader in knowledge extraction and artificial intelligence, announced today an agreement with Alexandria Minerals Corporation based on the results generated by CARDS (Computer Aided Resources Detection Software) for their Cadillac Break properties. The fee to use CARDS and right to use the targets provided by CARDS for this project is 70,000 CDN."The Cadilla
BROSSARD, QUEBEC — (Marketwired) — 12/03/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces today, from a Puma Exploration Inc. ("PUMA") news release dated November 20, 2014, the discovery of an extension of the Turgeon South Zone-Bern Zone that was first identified in 2012. As a direct result of prospecting a CARDS target defined by DIAGNO
BROSSARD, QUEBEC — (Marketwired) — 11/25/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the opening of its Mexican Subsidiary, Diagnos Internacional, S.A. de C.V..According to the International Diabetes Federation, Mexico has the 6th largest diabetic population in the world. With a population of 8.7
BROSSARD, QUEBEC — (Marketwired) — 11/19/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the resignation of Mr. Olivier Lerolle as a director and Chairman of the audit committee of DIAGNOS. Mr. Lerolle is resigning from the DIAGNOS Board for health and personal reasons."On behalf of my fellow mem
BROSSARD, QUEBEC — (Marketwired) — 10/16/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including screening, software and algorithm development, data analysis, and image processing, announces today the opening of a clinical retinopathy screening office in Algeria.Diabetic retinopathy is the most common diabetic eye disease and a leading cause of blindness around the world. It is a treatable disease that, as
BROSSARD, QUEBEC — (Marketwired) — 10/02/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), leader in healthcare technical services including, screening, software and algorithm development, data analysis, and image processing, announces today a first half fiscal-year update on the commercialization of CARA.The CARA suite of applications and services allows the different players in the diabetes screening process to make better informed decisions in the
BROSSARD, QUEBEC — (Marketwired) — 09/25/14 — DIAGNOS Inc. ("DIAGNOS" or "the Corporation") (TSX VENTURE: ADK), a leader in the use of artificial intelligence and advanced knowledge-extraction techniques, announces today that the shareholders of the Corporation have approved an amendment to the Corporation–s Stock Option Plan pursuant to which the exercise period of stock options held by Directors upon termination is extended from three (3) months to twelve (12) months.
